Raia Drogasil | RADL3


EPS Reference Time Actual Consensus Previous
2026-05-05 FY2026Q1 0.17 0.18 0.14
2026-03-03 FY2025Q4 0.18 0.2 0.20
2025-11-04 FY2025Q3 0.21 0.18 0.17
2025-08-05 FY2025Q2 0.23 0.17 0.20
2025-05-06 FY2025Q1 0.14 0.18 0.12



Peers Price Chg Day Year Date
Alliar Medicos A Frente 3.12 -0.10 -3.11% -43.58% Jun/03
Marisa Lojas 0.60 0 0% -58.90% Jun/03
Arezzo Industria e Comercio 17.38 -1.61 -8.48% -60.23% Jun/03
Americanas 4.88 -0.23 -4.50% -14.83% Jun/03
C&A Modas 10.95 -0.51 -4.45% -38.38% Jun/03
Clicks 23,518.00 69.00 0.29% -38.26% Jun/04
Grup SBF 10.59 -0.75 -6.61% -12.48% Jun/03
Cogna Educacao 2.39 -0.10 -4.02% -24.13% Jun/03
Fleury 14.70 -0.63 -4.11% 12.56% Jun/03
Fomento Economico Mexicano 122.53 0.72 0.59% 16.38% Jun/04

Indexes Price Day Year Date
IBOVESPA 170331 -3,867.02 -2.22% 24.33% Jun/03

Raia Drogasil traded at 17.51 this Wednesday June 3rd, decreasing 0.59 or 3.26 percent since the previous trading session. Looking back, over the last four weeks, Raia Drogasil lost 18.56 percent. Over the last 12 months, its price rose by 20.68 percent. Looking ahead, we forecast Raia Drogasil to be priced at 18.17 by the end of this quarter and at 16.70 in one year, according to Trading Economics global macro models projections and analysts expectations.

Raia Drogasil SA is a Brazil-based company engaged in retail sales of medications, specialty medicines, perfumery, personal care and beauty products, cosmetics and dermocosmetics. The Company’s sales are carried out by over 860 stores, located in the states of Sao Paulo, Minas Gerais, Rio de Janeiro, Parana, Goias, Espirito Santo, Santa Catarina, Rio Grande do Sul, Bahia, Mato Grosso and Mato Grosso do Sul and in the Distrito Federal. The Company operates through a range of subsidiaries, such as Raia SA and 4-Bio Medicamentos SA.